Medicus Pharma Ltd. (MDCX)

Medicus Pharma Statistics

Total Valuation

Medicus Pharma has a market cap or net worth of $11.79 million. The enterprise value is $8.66 million.

Market Cap	11.79M
Enterprise Value	8.66M

Important Dates

The next estimated earnings date is Monday, May 11, 2026, after market close.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Medicus Pharma has 39.36 million shares outstanding. The number of shares has increased by 79.68% in one year.

Current Share Class	39.36M
Shares Outstanding	39.36M
Shares Change (YoY)	+79.68%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	9.41%
Owned by Institutions (%)	12.04%
Float	32.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	318.71
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 146.79.

Current Ratio	1.00
Quick Ratio	0.88
Debt / Equity	146.79
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-129.91

Financial Efficiency

Return on equity (ROE) is -2,981.18% and return on invested capital (ROIC) is -357.28%.

Return on Equity (ROE)	-2,981.18%
Return on Assets (ROA)	-204.05%
Return on Invested Capital (ROIC)	-357.28%
Return on Capital Employed (ROCE)	-20,793.76%
Weighted Average Cost of Capital (WACC)	3.67%
Revenue Per Employee	n/a
Profits Per Employee	-$2.96M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.95% in the last 52 weeks. The beta is -0.04, so Medicus Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	-91.95%
50-Day Moving Average	0.75
200-Day Moving Average	1.83
Relative Strength Index (RSI)	28.02
Average Volume (20 Days)	5,961,542

Short Selling Information

The latest short interest is 3.56 million, so 9.04% of the outstanding shares have been sold short.

Short Interest	3.56M
Short Previous Month	1.04M
Short % of Shares Out	9.04%
Short % of Float	10.85%
Short Ratio (days to cover)	0.35

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.64M
Pretax Income	-47.28M
Net Income	-47.28M
EBITDA	n/a
EBIT	-25.64M
Earnings Per Share (EPS)	-$2.74

Balance Sheet

The company has $8.71 million in cash and $5.48 million in debt, with a net cash position of $3.23 million or $0.08 per share.

Cash & Cash Equivalents	8.71M
Total Debt	5.48M
Net Cash	3.23M
Net Cash Per Share	$0.08
Equity (Book Value)	37,311
Book Value Per Share	-0.00
Working Capital	-47,418

Cash Flow

Operating Cash Flow	-22.78M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	4.48M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medicus Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-79.68%
Shareholder Yield	-79.68%
Earnings Yield	-397.61%
FCF Yield	n/a

Analyst Forecast

The average price target for Medicus Pharma is $23.50, which is 7,746.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.50
Price Target Difference	7,746.41%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 25, 2024. It was a reverse split with a ratio of 1:2.

Last Split Date	Oct 25, 2024
Split Type	Reverse
Split Ratio	1:2

Scores

Altman Z-Score	n/a
Piotroski F-Score	1